Cardiac biomarkers, such as BNP and NT-proBNP, have shown prognostic value in patients at various stages of kidney dysfunction, and therefore have potential applications in patients with CRS types 2 or 428. The gene discussed is NPPB; the disease is congenital rubella syndrome.